Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / ADMA Biologics Securities Class Action
Regulatory class action

ADMA Biologics Securities Class Action

Analysis based on 294 articles · First reported Jun 14, 2026 · Last updated Aug 10, 2026

Sentiment
-60
Attention
2
Articles
294
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit and allegations of accounting irregularities have negatively impacted ADMA Biologics' stock price and investor confidence. The company faces potential financial liability and reputational damage, which could affect its ability to raise capital and its overall market valuation.

Biotechnology Pharmaceuticals
Event Summary

A securities class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ: ADMA) and certain of its executives, alleging violations of federal securities laws during the Class Period from August 9, 2024 to March 25, 2026. The complaint, Mazzarino v. ADMA Biologics, Inc., et al., No. 26-cv-04793, is pending in the United States — United States District Court for the District of New Jersey. The plaintiffs allege that ADMA engaged in an undisclosed related party transaction, used channel stuffing to create an appearance of revenue, and lacked adequate internal controls, making its public statements materially false and misleading. When the truth emerged through corrective disclosures, the stock price plummeted, causing substantial investor losses. Multiple law firms, including Kahn Swick & Foti, Bronstein Gewirtz & Grossman, Rosen Law Firm, Hagens Berman, and others, are soliciting investors to join the action and reminding them of the August 10, 2026 lead plaintiff deadline. The lawsuit seeks to recover damages for investors who purchased ADMA securities during the Class Period.

Key Actions
100 Berger Montague filed class action ADMA Biologics
94 Culper Research published report
94 The Law Offices of Frank R. Cruz filed class action lawsuits
93 ADMA Biologics issued misleading information
90 Bleichmar Fonti & Auld LLP announced investigation ADMA Biologics
90 Culper Research published report ADMA Biologics
90 Robbins Geller Rudman & Dowd LLP announced class action ADMA Biologics
90 ADMA Biologics issued misleading statements
90 Culper Research published report ADMA Biologics
90 ADMA Biologics concealed channel stuffing
89 Kahn Swick & Foti notifies investors
85 Bronstein, Gewirtz & Grossman, LLC announced class action
85 ADMA Biologics omitted related party sales Genesis BioPharma Services
85 ADMA Biologics certified controls effective
80 Robbins Geller Rudman & Dowd LLP announced class action
+ 20 more actions View on Dashboard
Entities Involved
stock
ADMA Biologics
ADMA Biologics is the defendant in the securities class action, accused of making false and misleading statements. The lawsuit and allegations have led to a significant drop in its stock price and could result in substantial financial penalties and reputational harm.
Importance 100.0 Sentiment -80.0
priv
Bronstein, Gewirtz & Grossman, LLC
Bronstein, Gewirtz & Grossman, LLC is another law firm involved in the class action, representing investors and seeking lead plaintiff appointments. The firm benefits from the litigation.
Importance 70.0 Sentiment 20.0
priv
Hagens Berman
Hagens Berman is investigating the claims and representing investors in the class action. The firm is seeking clients and may benefit from a settlement.
Importance 70.0 Sentiment 20.0
priv
Rosen Law Firm
The Rosen Law Firm is a lead plaintiff in the class action, having filed the first complaint. It is actively recruiting investors and stands to gain from a favorable outcome.
Importance 70.0 Sentiment 20.0
priv
Kahn Swick & Foti
Kahn Swick & Foti is one of the law firms representing investors in the class action, actively soliciting clients and reminding them of the lead plaintiff deadline. The firm stands to gain from a successful settlement.
Importance 70.0 Sentiment 20.0
priv
Genesis BioPharma Services
Genesis BioPharma Services is the undisclosed related party allegedly involved in the channel stuffing scheme, operating from ADMA's headquarters and sharing ownership ties with the Grossman family. The allegations implicate the entity in the fraud.
Importance 60.0 Sentiment -50.0
priv
Glancy Prongay & Murray
Glancy Prongay & Murray is involved in the class action, reminding investors of the deadline and seeking lead plaintiff roles. It stands to gain from the litigation.
Importance 60.0 Sentiment 20.0
priv
The Law Offices of Frank R. Cruz
The The Law Offices of Frank R. Cruz is involved in the class action, reminding investors of the deadline and seeking lead plaintiff roles. It stands to gain from the litigation.
Importance 60.0 Sentiment 20.0
priv
The Schall Law Firm
The The Schall Law Firm is involved in the class action, reminding investors of the deadline and seeking lead plaintiff roles. It stands to gain from the litigation.
Importance 60.0 Sentiment 20.0
priv
Schall Brown & Schwartz LLP
Schall Brown & Schwartz LLP is a law firm involved in the class action, representing investors and seeking lead plaintiff appointments. It benefits from the litigation.
Importance 60.0 Sentiment 20.0
priv
DJS Law Group
DJS Law Group is involved in the class action, reminding investors of the deadline and seeking lead plaintiff roles. It stands to gain from the litigation.
Importance 60.0 Sentiment 20.0
govactor
United States — United States District Court for the District of New Jersey
The court is overseeing the class action lawsuit. Its rulings will determine the outcome of the case.
Importance 50.0 Sentiment 0.0
priv
Culper Research
Culper Research published a report alleging channel stuffing and undisclosed related party transactions at ADMA, triggering the stock decline and subsequent lawsuits.
Importance 40.0 Sentiment 0.0
priv
Levi & Korsinsky
Levi & Korsinsky, through its SueWallSt brand, is alerting investors to the class action and providing case evaluations.
Importance 40.0 Sentiment 15.0
priv
GenesisBPS
GenesisBPS is the disclosed affiliate in ADMA's related party transaction notes, but the lawsuit alleges that sales to Genesis BioPharma Services were omitted, highlighting the undisclosed relationship.
Importance 40.0 Sentiment -40.0
+ 27 more entities View on Dashboard
Relationships
ADMA Biologics related ↔ Rosen Law Firm
ADMA Biologics related ↔ Kahn Swick & Foti
Bronstein, Gewirtz & Grossman, LLC related ↔ Hagens Berman
Bronstein, Gewirtz & Grossman, LLC co-counsel ↔ Rosen Law Firm Bronstein, Gewirtz & Grossman, LLC frequently collaborates with Rosen Law Firm as co-counsel on investor-rights class ac
Bronstein, Gewirtz & Grossman, LLC co-counsel ↔ Kahn Swick & Foti Bronstein, Gewirtz & Grossman, LLC frequently collaborates with Kahn Swick & Foti as co-counsel on numerous securities c
Bronstein, Gewirtz & Grossman, LLC co-counsel ↔ Glancy Prongay & Murray Bronstein, Gewirtz & Grossman, LLC frequently acts as co-counsel with Glancy Prongay & Murray in various securities clas
Bronstein, Gewirtz & Grossman, LLC competitor ↔ The Law Offices of Frank R. Cruz Bronstein, Gewirtz & Grossman, LLC is a plaintiff law firm that directly competes with The Law Offices of Frank R. Cruz
Bronstein, Gewirtz & Grossman, LLC co-counsel ↔ The Schall Law Firm Bronstein, Gewirtz & Grossman, LLC frequently collaborates with The Schall Law Firm as co-counsel in numerous securities
Bronstein, Gewirtz & Grossman, LLC co-plaintiffs ↔ Schall Brown & Schwartz LLP Bronstein, Gewirtz & Grossman, LLC and Schall Brown & Schwartz LLP frequently act as co-plaintiffs or pursue parallel le
Hagens Berman legal rivals ↔ Rosen Law Firm Hagens Berman frequently acts as a co-plaintiff with Rosen Law Firm in securities class action lawsuits against various
Hagens Berman co-counsel ↔ Kahn Swick & Foti Hagens Berman frequently acts as co-counsel with Kahn Swick & Foti in securities class action lawsuits, representing inv
Hagens Berman related ↔ Glancy Prongay & Murray
Hagens Berman related ↔ The Law Offices of Frank R. Cruz
Hagens Berman competitor ↔ The Schall Law Firm Hagens Berman competes directly with The Schall Law Firm in the plaintiff-side securities class action market.
Hagens Berman related ↔ Schall Brown & Schwartz LLP
+ 15 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.